These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 20596793

  • 1. Adrenomedullin 2/intermedin in the hypothalamo-pituitary-adrenal axis.
    Takahashi K, Morimoto R, Hirose T, Satoh F, Totsune K.
    J Mol Neurosci; 2011 Feb; 43(2):182-92. PubMed ID: 20596793
    [Abstract] [Full Text] [Related]

  • 2. Structure-function analyses reveal a triple β-turn receptor-bound conformation of adrenomedullin 2/intermedin and enable peptide antagonist design.
    Roehrkasse AM, Booe JM, Lee SM, Warner ML, Pioszak AA.
    J Biol Chem; 2018 Oct 12; 293(41):15840-15854. PubMed ID: 30139742
    [Abstract] [Full Text] [Related]

  • 3. Expression of adrenomedullin 2/intermedin in human adrenal tumors and attached non-neoplastic adrenal tissues.
    Morimoto R, Satoh F, Murakami O, Hirose T, Totsune K, Imai Y, Arai Y, Suzuki T, Sasano H, Ito S, Takahashi K.
    J Endocrinol; 2008 Jul 12; 198(1):175-83. PubMed ID: 18460550
    [Abstract] [Full Text] [Related]

  • 4. Adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin2 G protein-coupled receptor.
    Babin KM, Karim JA, Gordon PH, Lennon J, Dickson A, Pioszak AA.
    J Biol Chem; 2023 Jun 12; 299(6):104785. PubMed ID: 37146967
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor: implications for adrenomedullin and calcitonin gene-related peptide pharmacology.
    Watkins HA, Walker CS, Ly KN, Bailey RJ, Barwell J, Poyner DR, Hay DL.
    Br J Pharmacol; 2014 Feb 12; 171(3):772-88. PubMed ID: 24199627
    [Abstract] [Full Text] [Related]

  • 9. Protective effects of intermedin/adrenomedullin-2 in a cellular model of human pulmonary arterial hypertension.
    Holmes D, Corr M, Thomas G, Harbinson M, Campbell M, Spiers P, Bell D.
    Peptides; 2020 Apr 12; 126():170267. PubMed ID: 32017948
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes.
    Roh J, Chang CL, Bhalla A, Klein C, Hsu SY.
    J Biol Chem; 2004 Feb 20; 279(8):7264-74. PubMed ID: 14615490
    [Abstract] [Full Text] [Related]

  • 12. Expression of adrenomedullin 2/intermedin, a possible reno-protective peptide, is decreased in the kidneys of rats with hypertension or renal failure.
    Hirose T, Totsune K, Mori N, Mori T, Morimoto R, Metoki H, Asayama K, Kikuya M, Ohkubo T, Kohzuki M, Takahashi K, Imai Y.
    Am J Physiol Renal Physiol; 2010 Jul 20; 299(1):F128-34. PubMed ID: 20462970
    [Abstract] [Full Text] [Related]

  • 13. Changes in the expression of calcitonin receptor-like receptor, receptor activity-modifying protein (RAMP) 1, RAMP2, and RAMP3 in rat uterus during pregnancy, labor, and by steroid hormone treatments.
    Thota C, Gangula PR, Dong YL, Yallampalli C.
    Biol Reprod; 2003 Oct 20; 69(4):1432-7. PubMed ID: 12801991
    [Abstract] [Full Text] [Related]

  • 14. The pharmacology of adrenomedullin 2/intermedin.
    Hong Y, Hay DL, Quirion R, Poyner DR.
    Br J Pharmacol; 2012 May 20; 166(1):110-20. PubMed ID: 21658025
    [Abstract] [Full Text] [Related]

  • 15. Differential expression of components of the cardiomyocyte adrenomedullin/intermedin receptor system following blood pressure reduction in nitric oxide-deficient hypertension.
    Zhao Y, Bell D, Smith LR, Zhao L, Devine AB, McHenry EM, Nicholls DP, McDermott BJ.
    J Pharmacol Exp Ther; 2006 Mar 20; 316(3):1269-81. PubMed ID: 16326922
    [Abstract] [Full Text] [Related]

  • 16. Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins.
    Moad HE, Pioszak AA.
    Protein Sci; 2013 Dec 20; 22(12):1775-85. PubMed ID: 24115156
    [Abstract] [Full Text] [Related]

  • 17. Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat.
    Oliver KR, Kane SA, Salvatore CA, Mallee JJ, Kinsey AM, Koblan KS, Keyvan-Fouladi N, Heavens RP, Wainwright A, Jacobson M, Dickerson IM, Hill RG.
    Eur J Neurosci; 2001 Aug 20; 14(4):618-28. PubMed ID: 11556887
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the expression of calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) with CGRP and adrenomedullin binding in cell lines.
    Choksi T, Hay DL, Legon S, Poyner DR, Hagner S, Bloom SR, Smith DM.
    Br J Pharmacol; 2002 Jul 20; 136(5):784-92. PubMed ID: 12086988
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological characterisation of the mechanisms underlying the relaxant effect of adrenomedullin in the rat carotid artery.
    Passaglia P, Gonzaga NA, Tirapelli DP, Tirapelli LF, Tirapelli CR.
    J Pharm Pharmacol; 2014 Dec 20; 66(12):1734-46. PubMed ID: 25117796
    [Abstract] [Full Text] [Related]

  • 20. Changes of adrenomedullin and its receptor components mRNAs expression in the brain stem and hypothalamus-pituitary-adrenal axis of stress-induced hypertensive rats.
    Li X, Li L, Shen LL, Qian Y, Cao YX, Zhu DN.
    Sheng Li Xue Bao; 2004 Dec 25; 56(6):723-9. PubMed ID: 15614422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.